Characteristics of diabetes mellitus patients in Turkey: An analysis of national electronic health records.
Diabetes mellitus
electronic health records
epidemiology
healthcare utilization
Journal
Turkish journal of medical sciences
ISSN: 1303-6165
Titre abrégé: Turk J Med Sci
Pays: Turkey
ID NLM: 9441758
Informations de publication
Date de publication:
Feb 2023
Feb 2023
Historique:
received:
21
07
2022
accepted:
26
12
2022
entrez:
22
3
2023
pubmed:
23
3
2023
medline:
24
3
2023
Statut:
ppublish
Résumé
It was estimated that there were 537 million people with diabetes mellitus in 2021, representing 10.5% of the global adult population. Diabetes prevalence in Turkey is 13.5%, according to a meta-analysis and 17.3% according to a recent study. Although the primary purpose of Electronic Health Records (EHRs) is clinical, researchers can use them to conduct epidemiologic investigations. This study aims to document the prevalence of diabetes and to evaluate the healthcare utilization of people with diabetes compared to the people without diabetes, based on national EHR. Only people over 14 years old were included in the analysis. Our criteria for being diabetic were 1) having an HbA1c over 6.5% (48 mmol/mol), 2) having a prescription with DM diagnosis, ICD-10 codes E10-E14, or 3) having at least two fasting blood glucose measurements over 126 mg/dl. At the end of 2020, there were 7,178,674 individuals with diabetes, with 11.12% prevalence, 13.10% in women while 9.12% in men. Age-adjusted healthcare facility admission per capita was 15.5 for people with diabetes, 9.5 for people without diabetes, while the number of prescriptions was 7.9 for people with diabetes while 4.5 for people without diabetes in 2019. The mean number of prescriptions containing antidiabetics was 2.88 per person with diabetes in 2019. Approximately 11% of Turkish people have diagnosed with diabetes. We estimate that about one-third of people with diabetes are undiagnosed and the majority of these people are men. The results show that such large databases have the capability of supplying a vast amount of information to the scientific community.
Sections du résumé
BACKGROUND
BACKGROUND
It was estimated that there were 537 million people with diabetes mellitus in 2021, representing 10.5% of the global adult population. Diabetes prevalence in Turkey is 13.5%, according to a meta-analysis and 17.3% according to a recent study. Although the primary purpose of Electronic Health Records (EHRs) is clinical, researchers can use them to conduct epidemiologic investigations. This study aims to document the prevalence of diabetes and to evaluate the healthcare utilization of people with diabetes compared to the people without diabetes, based on national EHR.
METHODS
METHODS
Only people over 14 years old were included in the analysis. Our criteria for being diabetic were 1) having an HbA1c over 6.5% (48 mmol/mol), 2) having a prescription with DM diagnosis, ICD-10 codes E10-E14, or 3) having at least two fasting blood glucose measurements over 126 mg/dl.
RESULTS
RESULTS
At the end of 2020, there were 7,178,674 individuals with diabetes, with 11.12% prevalence, 13.10% in women while 9.12% in men. Age-adjusted healthcare facility admission per capita was 15.5 for people with diabetes, 9.5 for people without diabetes, while the number of prescriptions was 7.9 for people with diabetes while 4.5 for people without diabetes in 2019. The mean number of prescriptions containing antidiabetics was 2.88 per person with diabetes in 2019.
DISCUSSION
CONCLUSIONS
Approximately 11% of Turkish people have diagnosed with diabetes. We estimate that about one-third of people with diabetes are undiagnosed and the majority of these people are men. The results show that such large databases have the capability of supplying a vast amount of information to the scientific community.
Identifiants
pubmed: 36945956
doi: 10.55730/1300-0144.5587
pmc: PMC10387848
doi:
Substances chimiques
Blood Glucose
0
Hypoglycemic Agents
0
Types de publication
Meta-Analysis
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
316-322Références
Curr Vasc Pharmacol. 2020;18(2):104-109
pubmed: 30961501
Diabetes Res Clin Pract. 2007 Mar;75(3):313-9
pubmed: 16934906
Yearb Med Inform. 2014 May 22;9:228-34
pubmed: 24853036
Acta Diabetol. 2021 Mar;58(3):267-278
pubmed: 32770407
Turk Kardiyol Dern Ars. 2018 Oct;46(7):546-555
pubmed: 30391984
Diabetes Care. 2021 Jan;44(Suppl 1):S15-S33
pubmed: 33298413
Diabet Med. 2018 Dec;35(12):1727-1734
pubmed: 30153351
J Am Med Inform Assoc. 2013 Dec;20(e2):e319-26
pubmed: 24026307
Annu Rev Public Health. 2016;37:61-81
pubmed: 26667605
Diabetologia. 2017 Sep;60(9):1566-1576
pubmed: 28776081
Diabetes Res Clin Pract. 2022 Jan;183:109119
pubmed: 34879977
Diabetes Care. 2018 May;41(5):917-928
pubmed: 29567642
Nat Rev Endocrinol. 2016 Oct;12(10):616-22
pubmed: 27388988
Diabet Med. 2012 Jun;29(6):784-91
pubmed: 22050477
Adv Ther. 2019 Jan;36(1):44-58
pubmed: 30465123
Chin Med J (Engl). 2020 May 20;133(10):1224-1230
pubmed: 32433055
J Am Med Inform Assoc. 2017 Apr 01;24(e1):e121-e128
pubmed: 27616701